Edges in Network
| Network | GSE16446_top8000 - GSE16446 - SiGN-BN NNSR |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | MAML2 |
| Upstream (Parents) |
|---|
| (<<) SYNM → MAML2 |
| (<<) IRS2 → MAML2 |
| (<<) LOC100131541 → MAML2 |
| (<<) MFSD2A → MAML2 |
| (<<) JRKL → MAML2 |
| (<<) MRPL41 → MAML2 |
| Downstream (Children) |
|---|
| MAML2 → VGLL1 (>>) |
| MAML2 → KRT15 (>>) |
| MAML2 → NQO1 (>>) |
| MAML2 → S100A14 (>>) |
| MAML2 → IRS2 (>>) |
| MAML2 → UBASH3B (>>) |
| MAML2 → FABP6 (>>) |
| MAML2 → MOBKL2B (>>) |
| MAML2 → PDE1C (>>) |
| MAML2 → BOC (>>) |
| MAML2 → MFSD2A (>>) |
| MAML2 → OSBPL1A (>>) |
| MAML2 → JRKL (>>) |
| MAML2 → TMEM63C (>>) |
| MAML2 → CREB3L2 (>>) |
| MAML2 → TCF7L2 (>>) |
| MAML2 → GGCT (>>) |
| MAML2 → C9orf116 (>>) |
| MAML2 → CCDC82 (>>) |
